Shares of The Clorox Company (NYSE:CLX – Get Free Report) have been assigned an average recommendation of “Reduce” from the fourteen ratings firms that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $151.23.
Several analysts have recently weighed in on CLX shares. Evercore ISI set a $140.00 price target on Clorox and gave the stock an “underperform” rating in a report on Tuesday. Barclays decreased their price target on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. cut their price target on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a report on Tuesday. Wells Fargo & Company decreased their price objective on Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Morgan Stanley reduced their price target on Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research report on Tuesday.
Get Our Latest Report on Clorox
Insider Transactions at Clorox
Institutional Trading of Clorox
Hedge funds and other institutional investors have recently bought and sold shares of the business. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Redwood Park Advisors LLC purchased a new stake in shares of Clorox in the fourth quarter worth approximately $26,000. Millstone Evans Group LLC purchased a new position in shares of Clorox during the fourth quarter valued at approximately $31,000. Wood Tarver Financial Group LLC bought a new stake in Clorox during the fourth quarter worth $31,000. Finally, Asset Planning Inc purchased a new stake in Clorox in the 4th quarter valued at $32,000. Institutional investors own 78.53% of the company’s stock.
Clorox Trading Down 2.2 %
Shares of Clorox stock opened at $134.79 on Wednesday. The firm’s 50 day moving average is $142.37 and its 200 day moving average is $154.10. The firm has a market capitalization of $16.60 billion, a PE ratio of 36.83, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm’s quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company posted $1.71 earnings per share. Equities research analysts forecast that Clorox will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.62%. The ex-dividend date of this dividend was Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 87.61%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Using the MarketBeat Stock Split Calculator
- Google Is Betting Big on Nuclear Reactors—Should You?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Stock Sentiment Analysis: How it Works
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.